Daniel R Richardson
Overview
Explore the profile of Daniel R Richardson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
LoCastro M, Wang Y, Sanapala C, Jensen-Battaglia M, Wittink M, Norton S, et al.
J Geriatr Oncol
. 2023 May;
14(5):101529.
PMID: 37244139
Introduction: Acute myeloid leukemia (AML) is associated with poor outcomes and is generally incurable. Therefore, understanding preferences of older adults with AML is critical. We sought to assess whether best-worst...
12.
Retter J, Koll M, Dedic C, Danehy P, Richardson D, Kearney S
Appl Opt
. 2023 Jan;
62(1):50-62.
PMID: 36606849
We demonstrate a hybrid time-frequency spectroscopic method for simultaneous temperature/pressure measurements in nonreacting compressible flows with known gas composition. Hybrid femtosecond-picosecond, pure-rotational coherent anti-Stokes Raman scattering (CARS), with two independent,...
13.
LoCastro M, Sanapala C, Wang Y, Jensen-Battaglia M, Wittink M, Norton S, et al.
Cancer Med
. 2022 Dec;
12(7):8581-8593.
PMID: 36533397
Background: In a single-arm pilot study, we assessed the feasibility and usefulness of an innovative patient-centered communication tool (UR-GOAL tool) that addresses aging-related vulnerabilities, patient values, and prognostic awareness for...
14.
Richardson D, Parish P, Tan X, Fabricio J, Andreini C, Hicks C, et al.
JAMA Oncol
. 2022 Sep;
8(11):1616-1623.
PMID: 36136321
Importance: Monitoring of the corrected QT interval (QTc) for patients with cancer receiving chemotherapy is not standardized. Selection of QTc formula may be associated with adverse event grading and chemotherapy...
15.
Watson E, Sanapala C, Cortes A, Klepin H, Wittink M, Norton S, et al.
Blood Adv
. 2022 Aug;
6(21):5707-5710.
PMID: 35930701
No abstract available.
16.
Jensen C, Heiling H, Beke K, Deal A, Bryant A, Coombs L, et al.
Haematologica
. 2022 Jul;
108(4):1006-1014.
PMID: 35861016
Time at home is a critically important outcome to adults with acute myeloid leukemia (AML) when selecting treatment; however, no study to date has adequately described the amount of time...
17.
Cole A, Adapa K, Khasawneh A, Richardson D, Mazur L
BMJ Open
. 2022 Jul;
12(7):e058390.
PMID: 35793923
Objective: The primary aim was to review and synthesise the current evidence of how older adults are involved in codesign approaches to develop electronic healthcare tools (EHTs). The secondary aim...
18.
Cole A, Richardson D, Adapa K, Khasawneh A, Crossnohere N, Bridges J, et al.
JMIR Res Protoc
. 2022 Jun;
11(6):e39586.
PMID: 35767340
Background: The approval of novel therapies for patients diagnosed with hematologic malignancies have improved survival outcomes but increased the challenge of aligning chemotherapy choices with patient preferences. We previously developed...
19.
Cole A, Adapa K, Richardson D, Mazur L
Stud Health Technol Inform
. 2022 Jun;
290:1112-1113.
PMID: 35673231
We present evidence on the current state of utilizing co-design approaches involving older adults in developing electronic healthcare tools (EHTs). Research gaps were identified in defining the stages, involvement processes,...
20.
Retter J, Koll M, Richardson D, Kearney S
J Chem Phys
. 2022 May;
156(19):194201.
PMID: 35597636
We report pure-rotational N-N, N-air, and O-air S-branch linewidths for temperatures of 80-200 K by measuring the time-dependent decay of rotational Raman coherences in an isentropic free-jet expansion from a...